Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This ...
Former US president Joe Biden's prostate cancer is likely too advanced to be cured but treatment could control the spread of the disease for years, experts told AFP. The revelation late Sunday that ...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results